Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
作者:
主题词
青少年(Adolescent);成年人(Adult);自身抗体(Autoantibodies);人体质量指数(Body Mass Index);C肽(C-Peptide);糖尿病, 1型(Diabetes Mellitus, Type 1);糖尿病, 2型(Diabetes Mellitus, Type 2);诊断, 鉴别(Diagnosis, Differential);谷氨酸脱羧酶(Glutamate Decarboxylase);人类(Humans);降血糖药(Hypoglycemic Agents);胰岛素(Insulin);胰岛(Islets of Langerhans);同工酶类(Isoenzymes);试验预期值(Predictive Value of Tests);瑞典(Sweden)
DOI
10.1002/1520-7560(2000)9999:9999<::aid-dmrr152>3.0.co;2-t
PMID
11114103
发布时间
2022-03-31
- 浏览16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文